Akebia Therapeutics Inc. (AKBA) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Akebia Therapeutics Inc.

    NASDAQ: AKBA · Real-Time Price · USD
    2.83
    0.12 (4.43%)
    At close: Oct 03, 2025, 3:59 PM
    2.84
    0.35%
    Pre-market: Oct 06, 2025, 06:29 AM EDT

    Akebia Therapeutics Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -5.77 -4.48 -0.99 -1.53
    PEG Ratio
    		 -0.32 0.09 0.02 0.04
    PS Ratio
    		 2.50 1.19 0.36 1.76
    PB Ratio
    		 -8.15 -7.6 11.29 4.91
    P/FCF Ratio
    		 -9.85 -9.94 -1.44 -1.48
    P/OCF Ratio
    		 -9.86 -9.94 -1.44 -1.48
    OCF/S Ratio
    		 -0.25 -0.12 -0.25 -1.18
    Debt / Equity Ratio
    		 -0.97 -3.41 10.68 1.78
    Quick Ratio
    		 1.21 1.03 1.31 0.91
    Current Ratio
    		 1.41 1.18 1.48 1.06
    Asset Turnover
    		 0.73 0.81 0.83 0.41
    Interest Coverage
    		 -2.78 -7.67 -4.03 -13.31
    Return on Equity
    		 1.41 1.70 -11.35 -3.2
    Return on Assets
    		 -0.31 -0.21 -0.3 -0.47
    Return on Invested Capital
    		 -0.35 -0.28 -0.27 -0.62
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 0.61 0.62 0.71 0.28
    Net Profit Margin
    		 -0.43 -0.27 -0.36 -1.15
    Pretax Profit Margin
    		 -0.43 -0.27 -0.32 -1.32
    Operating Profit Margin
    		 -0.32 -0.24 -0.22 -1.24
    FCF Margin
    		 -0.25 -0.12 -0.25 -1.18
    EBITDA Margin
    		 -0.09 -0.04 -0.15 -1.06

    Add to Watchlist